MC5-22685-31421
3 vaccinations
1 coded response
22 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 297 / SC
- Registered
- 2021-01-13
- Relationship
- Self
- Race
- Black or African American
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-13
Registered in v-safe
-
2021-01-13
Dose 1 — Pfizer-BioNTech
- 2021-01-13
-
2021-01-14
Survey response — days 1–6 daily, dose 1MedDRA: Adverse reaction — Feeling: Good · Site: PainFree text: In injection siteMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-15
- 2021-01-17
- 2021-01-21
-
2021-02-02
Dose 2 — Pfizer-BioNTech
- 2021-02-03
- 2021-02-04
- 2021-02-05
- 2021-02-06
- 2021-02-07
- 2021-02-08
- 2021-02-09
- 2021-02-18
- 2021-03-04
- 2021-03-09
- 2021-05-04
- 2021-08-05
-
2021-09-08
Dose 3 — Pfizer-BioNTech
- 2021-09-30
- 2021-10-08
- 2021-10-13
- 2021-10-20
- 2021-12-08
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-13 | Pfizer-BioNTech | |
| 2 | 2021-02-02 | Pfizer-BioNTech | |
| 3 | 2021-09-08 | Pfizer-BioNTech | No |
Free text
Release 2 — days 1–6 daily, dose 1
Systemic reaction (other): In injection site
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Adverse reaction | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release